2024

1. Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data

   Journal of the European Academy of Dermatology and Venereology

2. The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

   Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1779-1789